Studies of D-penicillamine on Strain Variability and Lymph Node Cellularity in Adjuvant Arthritis

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1985 Sep 1

PMID 3934925

Authors

S Nakaike

K Takeshita

M Shiono

N Tomita

S Otomo

H Aihara

Affiliations

Soon will be listed here.

Abstract

Experiments were performed in order to ascertain the action of D-penicillamine (PA) on adjuvant arthritis (AA) in rats and to develop a quantitative evaluation method for PA-like drugs, using Lewis, SD, and Wistar rats. Rats were inoculated in the tail with 0.6 mg of Mycobacterium butyricum suspended in 0.1 ml of liquid paraffin. PA apparently induced enhancement of arthritis only in Lewis rats with a good reproducibility. The enhancing effect of PA was seen when it was administered during the period from day -7 to day -1, from day 0 to day 6, or from day 14 to day 20. In control group of Lewis and Wistar rats, adjuvant caused a rapid increase in the cell number of lymph nodes just after the inoculation, and also a marked increase in spleen cells coinciding with the development of arthritis. In PA-treated Lewis rats, the cell numbers of lymph nodes and spleen significantly surpassed those of control rats. However, PA induced no difference from control in Wistar rats, which were not sensitive to PA treatment during the course of arthritis. These results indicate that AA in Lewis rats is a good model for evaluating the activities of PA-like drugs and that PA may affect lymphocytes in lymph nodes and spleen and induce severer arthritis in Lewis rats.

References

Liyanage S, Currey H . Failure of oral D-penicillamine to modify adjuvant arthritis or immune response in the rat. Ann Rheum Dis. 1972; 31(6):521. PMC: 1005986. DOI: 10.1136/ard.31.6.521. View

Merryman P, Jaffee I . Effect of penicillamine on the proliferative response of human lymphocytes. Proc Soc Exp Biol Med. 1978; 157(1):155-8. DOI: 10.3181/00379727-157-40011. View

Fujimura H, Hiramatsu Y, Tamura Y, Yanagihara M, Koda A, Nagai H . [Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action (author's transl)]. Nihon Yakurigaku Zasshi. 1980; 76(2):117-29. View

Anderson A . Lysosomal enzyme activity in rats with adjuvant-induced arthritis. Ann Rheum Dis. 1970; 29(3):307-13. PMC: 1031266. DOI: 10.1136/ard.29.3.307. View

Kayashima K, Koga T, Onoue K . Role of T lymphocytes in adjuvant arthritis. II. Different subpopulations of T lymphocytes functioning in the development of the disease. J Immunol. 1978; 120(4):1127-31. View

Pearson C . EXPERIMENTAL JOINT DISEASE OBSERVATIONS ON ADJUVANT-INDUCED ARTHRITIS. J Chronic Dis. 1963; 16:863-74. DOI: 10.1016/0021-9681(63)90136-x. View

Klamer B, Kimura E, Makstenieks M . Effects of oral cysteine, penicillamine and N-acetyl-penicillamine on adjuvant arthritis in rats. Pharmacology. 1968; 1(5):283-8. DOI: 10.1159/000135976. View

Bramm E, Binderup L, ARRIGONI-MARTELLI E . Delayed hypersensitivity to tuberculin in rats: effects of antirheumatic drugs. Acta Pharmacol Toxicol (Copenh). 1979; 44(1):75-80. DOI: 10.1111/j.1600-0773.1979.tb02297.x. View

Berry H, Willoughby D, Giroud J . Evidence for an endogenous antigen in the adjuvant arthritic rat. J Pathol. 1973; 111(4):229-38. DOI: 10.1002/path.1711110403. View

10.

Baumgartner R, OBENAUS H, STOERK H . Suppression of adjuvant arthritis by penicillamine in pyridoxine deficient rats. Proc Soc Exp Biol Med. 1974; 146(1):241-4. DOI: 10.3181/00379727-146-38078. View

11.

Otomo S, Nakaike S, Tsuji I, Mori C, Ohzeki M . Studies of D-penicillamine (3): immunomodulating effects of D-penicillamine. Nihon Yakurigaku Zasshi. 1981; 77(3):313-20. View

12.

Toivonen M, Tokola O, Vapaatalo H . Rat adjuvant arthritis as a model to test potential antirheumatic agents. Methods Find Exp Clin Pharmacol. 1982; 4(6):359-63. View

13.

Bramm E . Investigations on the influence of cyclophosphamide, gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis. Agents Actions. 1975; 5(3):264-7. DOI: 10.1007/BF02026441. View

14.

Kayashima K, Koga T, Onoue K . Role of T lymphocytes in adjuvant arthritis. I. Evidence for the regulatory function of thymus-derived cells in the induction of the disease. J Immunol. 1976; 117(5 Pt.2):1878-82. View

15.

ARRIGONI-MARTELLI E, Bramm E . Development of models for penicillamine-like drugs. Rheumatol Rehabil. 1976; 15(3):207-10. DOI: 10.1093/rheumatology/15.3.207. View

16.

Binderup L, Bramm E, ARRIGONI-MARTELLI E . Immunological effects of D-penicillamine during experimental induced inflammation in rats. Scand J Immunol. 1980; 12(3):239-47. DOI: 10.1111/j.1365-3083.1980.tb00064.x. View

17.

Otomo S, Higuchi S, Nakaike S, Tarumoto Y, Kimura M, Sasajima M . [Studies of D-penicillamine (5): effects on rat adjuvant arthritis (author's transl)]. Nihon Yakurigaku Zasshi. 1981; 78(3):145-62. View

18.

Ohsugi Y, Hata S, Tanemura M, Nakano T, Matsuno T, Takagaki Y . N-(2-Carboxyphenyl)-4-chloroanthranilic acid disodium salt: a novel anti-arthritic agent without anti-inflammatory and immunosuppressive activities. J Pharm Pharmacol. 1977; 29(10):636-7. DOI: 10.1111/j.2042-7158.1977.tb11422.x. View